PLOS Pathogens Retracted Encephalitis Virus Study
Editors pulled a paper on viral metabolic manipulation after finding unresolved reliability issues in the reported data.
Updated on Sept. 21, 2026 in Life Sciences
The journal PLOS Pathogens has formally retracted a research paper concerning how the Japanese encephalitis virus orchestrates GLUT4-mediated glucose metabolism. Editors took the action after concluding that provided data and comments failed to address reliability concerns found throughout the study.
Why it matters
Retractions serve as an essential self-correction mechanism in scientific publishing to ensure the integrity of the academic record. This action follows an editorial investigation into multiple figures that failed to meet the journal's standards for reproducibility.
Editors identified reliability issues across seven distinct figures and supplemental panels. The review involved an analysis of uncropped blot data and comparative inspections of lanes and background noise patterns.
The players
PLOS Pathogens
An open-access peer-reviewed journal publishing research on pathogens and host-pathogen interactions.
BZ
The corresponding author of the retracted paper who maintains that the scientific findings remain valid.
YYG
A co-author of the study who agreed with the editorial decision to retract the work.
The details
The retracted study investigated how the Japanese encephalitis virus affects GLUT4, a protein that transports glucose into cells. The journal's editorial staff initiated the review by requesting uncropped blot data—raw images of the gel electrophoresis used to visualize proteins—and replacement panels for their figures. After comparing the alignment of experimental lanes and evaluating the consistency of background noise patterns, editors determined that the provided information did not sufficiently resolve the reliability concerns.
Timeline
September 21, 2026: The journal officially retracted the research article.
The Tech Race
This retraction marks a correction in the field of host-pathogen metabolic research, where precise data is required to identify therapeutic targets. It contrasts with the high bar for data validation established during the 2003 SARS response protocols.
Researchers and students in the field of virology should treat the findings of this paper as officially retracted. The notice informs the broader community that the data presented in the paper's figures should not be relied upon for current or future experimental models.
The takeaway
The retraction underscores the critical role of editorial scrutiny in identifying discrepancies in protein blot imaging. Future studies in the field should prioritize transparent data sharing and raw image disclosure to prevent similar reliability disputes.
Further reading
For more developments in this field, visit the Life Sciences section.
More information
Read the full journal retraction notice on the PLOS website.
Source note: This article includes information reported by PLOS.
